Delivery Order SPE2DB24D1021-SPE2DB25FEZZG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,266.54 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Adderall 5 mg tablets in quantities of 100 units, with a ceiling value of $1,899.03. The contract, awarded on August 18, 2025, carries a firm fixed price structure with an ultimate completion date of August 19, 2025. This non-set-aside competitive award represents a single delivery order under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order on August 5, 2025, by the Defense Logistics Agency to supply 100 tablets of Adderall 20 mg. The contract is a firm fixed-price delivery order with a ceiling value of $10,740.13 and an ultimate completion date of August 6, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,160.91 for 100 tablets of Adderall 15 mg on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 5 mg tablets (100-count units) with a ceiling value of $6,330.10. This firm fixed-price contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a competitively awarded, non-set-aside procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,937.02 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by August 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 12, 2025, with a ceiling value of $10,926.83 for the supply of Adderall 5 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $3,727.50 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of Adderall 5 mg tablets in 100-count bottles. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $5,232.37 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,335 units of Adderall 5 mg tablets. This delivery order contract was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical for the provision of a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) under a firm fixed-price contract valued at $2,739.72. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZZGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,793.21 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a firm fixed price and a completion deadline of August 26, 2025. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a $999.999 billion potential value through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic categories. The underlying SPE2DX IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning future Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/25/25 |